- Home
- NXTC vs MMA Comparison
NXTC vs MMA Comparison
Compare NXTC & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NXTC | MMA |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.6M | 20.2M |
| IPO Year | 2019 | 2024 |
Fundamental Metrics
Financial Performance| Metric | NXTC | MMA |
|---|---|---|
| Price | $11.49 | $1.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 55.0K | ★ 119.7K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $739,641.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 191.30 |
| 52 Week Low | $2.69 | $0.60 |
| 52 Week High | $15.74 | $3.07 |
Technical Indicators
Market Signals| Indicator | NXTC | MMA |
|---|---|---|
| Relative Strength Index (RSI) | 52.23 | 39.82 |
| Support Level | $10.38 | $1.24 |
| Resistance Level | $12.00 | $1.47 |
| Average True Range (ATR) | 1.01 | 0.10 |
| MACD | -0.23 | -0.01 |
| Stochastic Oscillator | 36.27 | 0.00 |
Price Performance
Historical ComparisonAbout NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.